Production (Stage)
Appili Therapeutics Inc.
APLI.TO
TSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 158.90K | -374.60K | -545.10K | -1.16M | -818.50K |
| Total Depreciation and Amortization | 2.20K | 2.90K | 2.10K | 2.50K | 2.50K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 699.40K | 650.90K | 313.50K | 996.60K | 154.30K |
| Change in Net Operating Assets | -139.90K | -595.20K | 529.40K | 62.70K | 322.90K |
| Cash from Operations | 720.60K | -316.00K | 299.90K | -96.50K | -338.70K |
| Capital Expenditure | 0.00 | -500.00 | -1.20K | -- | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | 500.00 |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 0.00 | -500.00 | -1.20K | -- | 500.00 |
| Total Debt Issued | 0.00 | 0.00 | 0.00 | 400.00K | 0.00 |
| Total Debt Repaid | -44.90K | -27.60K | -26.60K | -42.80K | -25.30K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -16.40K | -13.00K | -16.30K | -18.80K | -26.10K |
| Cash from Financing | -42.60K | -29.00K | -31.50K | 247.30K | -38.10K |
| Foreign Exchange rate Adjustments | 48.10K | 3.30K | -300.00 | 300.00 | -700.00 |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 726.10K | -342.20K | 266.80K | 151.10K | -377.10K |